ArticleInfectious diseases and therapy2024

First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study.

Hongzhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.